Cancer Chemotherapy and Pharmacology

, Volume 61, Issue 4, pp 717–720 | Cite as

A case of mixed adult Wilms’ tumour and angiosarcoma responsive to carboplatin, etoposide and vincristine (CEO)

  • Thomas Yau
  • C. H. Leong
  • W. K. Chan
  • J. K. Chan
  • R. H. S. Liang
  • R. J. Epstein
Short Communication


Here we report an unusual case of mixed Wilms’ tumour and angiosarcoma in a 38-year-old female patient who presented with haematuria and right lower back pain. A computed tomographic (CT) scan confirmed a massive renal tumour associated with extensive retroperitoneal lymph node involvement, bony metastases and a right hip fracture. She was initially managed with palliative nephrectomy, which was followed by rapid postoperative deterioration. Histopathology revealed differentiated adult Wilms’ tumour with renal angiosarcoma, whereas the pathology of the para-aortic lymph node and bone metastasis revealed angiosarcoma only. In view of her cachexia and cytopaenia, emergency chemotherapy was initiated using a modified regimen of carboplatin, etoposide and vincristine (CEO) in preference to the more traditional but less well-tolerated VAC (vincristine, actinomycin D, cyclophosphamide). Four cycles of this protocol yielded a dramatic response on re-staging CT scan. This case suggests that highly angiogenic tumours such as angiosarcoma may be effectively palliated using agents usually reserved for refractory Wilms’ tumour, and supports the view that adult Wilms’ tumour is more sensitive to such agents.


Adult Wilm’s tumour Angiosarcoma Drug therapy 


  1. 1.
    Arrigo S, Beckwith JB, Sharoles K, D’Angio G, Haase G (1990) Better survival after combined modality care for adults with Wilm’s tumor. Cancer 66:827–830PubMedCrossRefGoogle Scholar
  2. 2.
    Kattan J, Tournade MF, Culine S, Terrier-Lacombe MJ, Droz JP (1994) Adult Wilms’ tumour: review of 22 cases. Eur J Cancer 30A:1778–1782PubMedCrossRefGoogle Scholar
  3. 3.
    Williams G, Colbeck RA (1992) Gowing NFC: adult Wilms’ tumour: review of 14 patients. Br J Urol 70:230–235PubMedGoogle Scholar
  4. 4.
    Huser J, Grignon DJ, Ro JY, Ayala AG, Shannon RL, Papadopoulos NJ (1990) Adult Wilms’ tumor: a clinicopathologic study of 11 cases. Mod Pathol 3:321–326PubMedGoogle Scholar
  5. 5.
    Gutjahr P, Neisius D, Bode U (1992) Therapie und Prognose bei 11 Erwachsenen mit Wilms–Tumoren (Nephroblastome). Aktuelle Urol 23:232–235CrossRefGoogle Scholar
  6. 6.
    Camci C, Turk HM, Erkilic S, Buyukberber S, Uner A, Ozsarac C (2002) Early multimodal therapy in adult Wilms’ tumor: case report. J Chemother 14(5):530–532PubMedGoogle Scholar
  7. 7.
    Haouas N, Sahraoui W, Sridi K (2005) Adult Wilms tumour Prog Urol 15(2):326–328PubMedGoogle Scholar
  8. 8.
    Terenziani M, Spreafico F, Collini P, Piva L, Perotti D, Podda M et al (2004) Adult Wilms’ tumor: a monoinstitutional experience and a review of the literature. Cancer 101(2):289–293PubMedCrossRefGoogle Scholar
  9. 9.
    Kaur N, Gupta A, Attam A, Shrivastava UK, Wadhwa N (2005) Adult wilms’ tumor: management considerations. Int Urol Nephrol 37(1):17–20PubMedCrossRefGoogle Scholar
  10. 10.
    Kok VC, Liu TW, Lin HH, Ou H, Cheng SH, Liu MC et al (1995) Concomitant renal cell carcinoma and metastatic epithelioid angiosarcoma with microangiopathy. J Formos Med Assoc 94:48–52PubMedGoogle Scholar
  11. 11.
    Pathak S, Strong LC, Ferrell RE, Trindade (1982) A Familial renal cell carcinoma with a 3:11 chromosome translocation limited to tumor cells. Science 217:939–941PubMedCrossRefGoogle Scholar
  12. 12.
    Zbar B, Brauch H, Talmadge C, Linehan M (1987) Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma. Nature 327:721–724PubMedCrossRefGoogle Scholar
  13. 13.
    Fleming S (1998) Genetics of kidney tumours. Forum (Genova) 8:176–184Google Scholar
  14. 14.
    Rubin BP, Pins MR, Nielsen GP, Rosen S, His BL, Fletcher JA et al (2000) Isochromosome 7q in adult Wilms’ tumors: diagnostic and pathogenetic implications. Am J Surg Pathol 24:1663–1669PubMedCrossRefGoogle Scholar
  15. 15.
    Ueda T,Oji Y, naka N, Nakano Y, Takahashi E,Koga S et al (2003) Overexpression of the Wilms’ tumor gene WT1 in human bone and soft-tissue sarcomas. Cancer Sci 94(3):271–276PubMedCrossRefGoogle Scholar
  16. 16.
    Maher ER, Yates JR, Ferguson-Smith MA (1990) Statistical analysis of the two stage mutation model in VHL disease and in sporadic cerebellar haemangioblastoma and renal cell carcinoma. J Med Genet 27:311–314PubMedGoogle Scholar
  17. 17.
    Jamjoom A, Kane N, Nicoll J (1992) Metastasis of a renal carcinoma to a cerebellar haemangioblastoma in a case of von Hippel–Lindau disease. Neurosurg Rev 15:231–234PubMedCrossRefGoogle Scholar
  18. 18.
    Spreafico F, Fossati-Bellani F, Collini P (2003) Wilms’ tumor in adolescents and adults: What is required for a correct approach. Med Pediatr Oncol 41:267CrossRefGoogle Scholar
  19. 19.
    Kalapurakal JA, Nan B, Norkool P, Coppes M, Perlman E, Beckwith B et al (2004) Treatment outcomes in adults with favorable histologic type Wilms tumor-an update from the National Wilms Tumor Study Group. Int J Radiat Oncol Biol Phys 60:1379–1384PubMedCrossRefGoogle Scholar
  20. 20.
    Abu-Ghosh AM, Krailo MD, Goldman SC, Slack RS, Davenport V, Morris E et al (2002) Ifosfamide, carboplatin and etoposide in children with poor-risk relapsed Wilms’ tumor: a Children’s Cancer Group report. Ann Oncol 13(3):460–469PubMedCrossRefGoogle Scholar
  21. 21.
    Pein F, Tournade MF, Zucker JM, Brunat-Mentigny M, Deville A, Boutard P et al (1994) Etoposide and carboplatin: a highly effective combination in relapsed or refractory Wilms’ tumor-a phase II study by the French Society of Pediatric Oncology. J Clin Oncol 12(5):931–936PubMedGoogle Scholar
  22. 22.
    Pandian SS, McClinton S, Bissett D, Ewen SW (1997) Lactate dehydrogenase as a tumour marker in adult Wilm’s tumour. Br J Urol 80(4):670–671PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Thomas Yau
    • 1
  • C. H. Leong
    • 2
  • W. K. Chan
    • 3
  • J. K. Chan
    • 4
  • R. H. S. Liang
    • 1
  • R. J. Epstein
    • 1
  1. 1.Division of Haematology/Oncology, University Department of Medicine, Room 405, Professorial BlockQueen Mary HospitalPokfulamHong Kong
  2. 2.CentralHong Kong
  3. 3.Department of PathologyHong Kong Sanatorium HospitalHappy ValleyHong Kong
  4. 4.Department of PathologyQueen Elizabeth HospitalKowloonHong Kong

Personalised recommendations